Bariatric surgery can lower glucose levels and insulin and insulin-like growth factor-binding protein 1 (IGFBP-1); in addition, this surgery can improve insulin sensitivity in obese women and decreases inflammatory endometrial cancer risk biomarkers [56]. Here, IGFBP1 is linked to endometrial cancer.